hippocampal cholinergic neurostimulating peptide has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Argibay, P; Bassi, S; Seney, ML; Sibille, E | 1 |
| Furuya, Y; Matsukawa, N; Ogura, H; Ojika, K | 1 |
| Bian, JM; Chen, Y; Li, J; Su, RB; Wei, QH; Wu, N | 1 |
3 other study(ies) available for hippocampal cholinergic neurostimulating peptide and Disease Models, Animal
| Article | Year |
|---|---|
Elevated Hippocampal Cholinergic Neurostimulating Peptide precursor protein (HCNP-pp) mRNA in the amygdala in major depression.
Topics: Acetylcholinesterase; Adult; Amygdala; Analysis of Variance; Animals; Depressive Disorder, Major; Disease Models, Animal; Female; Humans; Male; Mice; Middle Aged; Neuropeptides; Postmortem Changes; Receptors, Muscarinic; RNA, Messenger; Sex Factors; Stress, Psychological; Up-Regulation; Young Adult | 2015 |
HCNP precursor protein transgenic mice display a depressive-like phenotype in old age.
Topics: Age Factors; Aging; Animals; Behavior, Animal; Choline O-Acetyltransferase; Depression; Disease Models, Animal; Exploratory Behavior; Hindlimb Suspension; Male; Maze Learning; Mice; Mice, Transgenic; Motor Activity; Neural Inhibition; Neuropeptides; Phenotype; Phosphatidylethanolamine Binding Protein; Swimming | 2010 |
Involvement of hippocampal phosphatidylethanolamine-binding protein in morphine dependence and withdrawal.
Topics: Analysis of Variance; Animals; Behavior, Addictive; Blotting, Western; Choline O-Acetyltransferase; Disease Models, Animal; Down-Regulation; Electrophoresis, Gel, Two-Dimensional; Hippocampus; Humans; Male; Morphine Dependence; Naloxone; Narcotic Antagonists; Neuropeptides; Oligonucleotides, Antisense; Phosphatidylethanolamine Binding Protein; Proteomics; Rats; Rats, Wistar; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Substance Withdrawal Syndrome; Thionucleotides; Up-Regulation | 2013 |